Human Genome Sciences (HGSI) Agrees to $14/Share Takeover from GSK (GSK) - Reports

July 16, 2012 6:37 AM EDT
Get Alerts HGSI Hot Sheet
Trade HGSI Now!
Join SI Premium – FREE
Human Genome Sciences Inc. (Nasdaq: HGSI) has agreed to be acquired by GlaxoSmithKline plc (NYSE: GSK) for $14 per share, or $1 per share above the prior bid, according to reports from Reuters.

Shares of Human Genome Sciences closed at $13.58 on Friday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot M&A, Mergers and Acquisitions, Rumors

Add Your Comment